Clotting Factors in COVID-19: Epidemiological Association and Prognostic Values in Different Clinical Presentations in an Italian Cohort.

Pierpaolo Di MiccoVincenzo RussoNovella CarannanteMichele ImparatoStefano Rodolfi Giuseppe CardilloCorrado Lodigiani

Published in: Journal of clinical medicine (2020)

Fibrinogen seems to increase early in COVID-19 patients and may be used as a risk stratification marker for the early detection of a subgroup of COVID-19 patient at increased risk to develop SARS, who might benefit from a different and thorough clinical surveillance and treatment.

Keyphrases

sars cov
coronavirus disease
public health
case report
randomized controlled trial
respiratory syndrome coronavirus
combination therapy